WallStSmart

Encompass Health Corp (EHC)vsNasdaq Inc (NDAQ)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Encompass Health Corp generates 12% more annual revenue ($6.07B vs $5.42B). NDAQ leads profitability with a 35.3% profit margin vs 10.0%. EHC appears more attractively valued with a PEG of 0.41. EHC earns a higher WallStSmart Score of 75/100 (B+).

EHC

Strong Buy

75

out of 100

Grade: B+

Growth: 8.0Profit: 8.0Value: 8.0Quality: 5.8
Piotroski: 5/9Altman Z: 2.09

NDAQ

Strong Buy

69

out of 100

Grade: B-

Growth: 7.3Profit: 8.5Value: 5.0Quality: 5.5
Piotroski: 5/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EHCUndervalued (+24.9%)

Margin of Safety

+24.9%

Fair Value

$150.95

Current Price

$106.10

$44.85 discount

UndervaluedFair: $150.95Overvalued

Intrinsic value data unavailable for NDAQ.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EHC3 strengths · Avg: 9.0/10
PEG RatioValuation
0.4110/10

Growing faster than its price suggests

Return on EquityProfitability
25.2%9/10

Every $100 of equity generates 25 in profit

EPS GrowthGrowth
30.3%8/10

Earnings expanding 30.3% YoY

NDAQ4 strengths · Avg: 9.3/10
Profit MarginProfitability
35.3%10/10

Keeps 35 of every $100 in revenue as profit

Operating MarginProfitability
48.4%10/10

Strong operational efficiency at 48.4%

Market CapQuality
$50.28B9/10

Large-cap with strong market position

EPS GrowthGrowth
33.8%8/10

Earnings expanding 33.8% YoY

Areas to Watch

EHC0 concerns · Avg: 0/10

No major concerns identified

NDAQ2 concerns · Avg: 4.0/10
PEG RatioValuation
2.324/10

Expensive relative to growth rate

P/E RatioValuation
26.8x4/10

Moderate valuation

Comparative Analysis Report

WallStSmart Research

Bull Case : EHC

The strongest argument for EHC centers on PEG Ratio, Return on Equity, EPS Growth. PEG of 0.41 suggests the stock is reasonably priced for its growth.

Bull Case : NDAQ

The strongest argument for NDAQ centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 35.3% and operating margin at 48.4%. Revenue growth of 13.7% demonstrates continued momentum.

Bear Case : EHC

No major red flags identified for EHC, but monitor valuation.

Bear Case : NDAQ

The primary concerns for NDAQ are PEG Ratio, P/E Ratio.

Key Dynamics to Monitor

EHC profiles as a value stock while NDAQ is a mature play — different risk/reward profiles.

NDAQ carries more volatility with a beta of 0.99 — expect wider price swings.

NDAQ is growing revenue faster at 13.7% — sustainability is the question.

NDAQ generates stronger free cash flow (629M), providing more financial flexibility.

Bottom Line

EHC scores higher overall (75/100 vs 69/100). Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Encompass Health Corp

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Encompass Health Corporation offers in-home and post-acute health care services in the United States. The company is headquartered in Birmingham, Alabama.

Nasdaq Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

Nasdaq, Inc. is an American multinational financial services corporation that owns and operates stock exchanges in the United States and Europe. It is headquartered in New York City.

Visit Website →

Want to dig deeper into these stocks?